San Francisco, CA, United States of America

Michele D Jumper

This inventor holds 3 USPTO granted patents. Top assignee: University of California. Active years: 2000-2006.


% Patents Active = 66.7

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 49(Granted Patents)


Location History:

  • SF, CA (US) (2000 - 2003)
  • San Francisco, CA (US) (2006)

Company Filing History:


Years Active: 2000-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michele D Jumper: Innovator in Eye Treatments

Introduction

Michele D Jumper is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of ophthalmology, particularly in the development of innovative treatments for eye conditions. With a total of 3 patents, her work focuses on utilizing synthetic thyroid hormones to address intraocular pressure issues.

Latest Patents

One of Michele's latest patents involves eye treatments using synthetic thyroid hormone compositions. This invention reveals that synthetic thyroid hormones can effectively reduce intraocular pressure in vivo. The patent outlines methods for screening these hormones for their effects on intraocular pressure, aqueous pressure, hydraulic conductivity, hyaluronic acid secretion, and extracellular matrix assembly. Additionally, it provides methods for treating glaucoma and managing excess intraocular pressure using these synthetic hormones.

Career Highlights

Michele D Jumper is affiliated with the University of California, where she continues her research and development in eye treatments. Her innovative approach has garnered attention in the medical community, contributing to advancements in glaucoma treatment.

Collaborations

Michele has collaborated with notable colleagues, including Thomas S Scanlan and Daniel M Schwartz. These partnerships have further enhanced her research efforts and the impact of her inventions.

Conclusion

Michele D Jumper's work in developing eye treatments using synthetic thyroid hormones represents a significant advancement in ophthalmology. Her contributions are paving the way for new therapeutic options for patients suffering from glaucoma and other eye conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…